Carniliv 1 gm Injection 5 ml

Carniliv 1 gm Injection 5 ml is indicated for the acute and chronic treatment of patients with an inborn error of metabolism that results in secondary carnitine deficiency. It is also indicated to prevent and treat carnitine deficiency in end-stage renal disease patients undergoing dialysis.

Carniliv 1 gm Injection 5 ml contains Levocarnitine, that works by improving the levels of carnitine in the body. It thereby helps treat carnitine deficiency.

In some cases, Carniliv 1 gm Injection 5 ml may cause nausea and vomiting. Most of these side effects of Carniliv 1 gm Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to any of the components in Carniliv 1 gm Injection 5 ml, please inform your doctor. Consult your doctor if you are pregnant or breastfeeding. Let your doctor know if you are taking any prescription or non-prescription medicines, including supplements and herbal products.

Carniliv 1 gm Injection 5 ml is used in the management and treatment of Carnitine deficiency. The detailed uses of Carniliv 1 gm Injection 5 ml are as follows:

• Treat carnitine deficiency: Carniliv 1 gm Injection 5 ml is primarily used to correct low levels of carnitine in the body, which can occur due to genetic disorders, chronic kidney disease, or certain medications. It helps improve energy production by facilitating the transport of fatty acids into mitochondria.
• Support metabolic function in dialysis patients: Carniliv 1 gm Injection 5 ml is administered to patients undergoing hemodialysis to prevent and treat secondary carnitine deficiency, improving muscle function and reducing fatigue.

• Carniliv 1 gm Injection 5 ml is administered by a healthcare professional, typically in a hospital or clinical setting, via intravenous (IV) injection.
• Your healthcare provider will determine the correct dosage and frequency based on your specific needs and medical history.
• Do not attempt to self-administer this injection. It should be administered by healthcare providers.
• Follow all the instructions given by your healthcare provider, including any monitoring or precautions you need to take during your treatment.

• Carniliv 1 gm Injection 5 ml is indicated for the acute and chronic treatment of patients with an inborn error of metabolism that results in secondary carnitine deficiency.
• It is also indicated to prevent and treat carnitine deficiency in end-stage renal disease patients undergoing dialysis.
• Carniliv 1 gm Injection 5 ml contains ‘Levocarnitine’, an amino acid that works by improving the levels of carnitine in the body.
• It may alleviate the metabolic abnormalities of patients with inborn errors that result in the accumulation of toxic organic acids.

• If you are allergic to any of the components in Carniliv 1 gm Injection 5 ml, please inform your doctor.
• Consult your doctor if you are pregnant or breastfeeding.
• Let your doctor know if you are taking any prescription or non-prescription medicines, including supplements and herbal products.